A September 17 BioPharma article pointed out that almost all of the biosimilars currently approved have been developed using a third-party research organisation according to a survey from the Association of Clinical Research Organizations (ACRO).
Read “Fastest Way to Biosimilar Approval? As the CRO flies” here.